BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33856430)

  • 1. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
    Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
    Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
    J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral atenolol therapy for proliferating infantile hemangioma: A prospective study.
    Ji Y; Wang Q; Chen S; Xiang B; Xu Z; Li Y; Zhong L; Jiang X; Yang X
    Medicine (Baltimore); 2016 Jun; 95(24):e3908. PubMed ID: 27310994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
    Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
    JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.
    Pope E; Lara-Corrales I; Sibbald C; Liy-Wong C; Kanigsberg N; Drolet B; Ma J
    JAMA Pediatr; 2022 Jan; 176(1):34-41. PubMed ID: 34747977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase: A Retrospective Noninferiority Study.
    Bayart CB; Tamburro JE; Vidimos AT; Wang L; Golden AB
    Pediatr Dermatol; 2017 Jul; 34(4):413-421. PubMed ID: 28556385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents.
    Hermans MM; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; Raphael MF; de Graaf M; Breugem CC; de Wildt SN; Okkerse JME; Pasmans SGMA; Rietman AB
    Dermatology; 2024; 240(2):216-225. PubMed ID: 38228125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol.
    Chen T; Gudipudi R; Nguyen SA; Carroll W; Clemmens C
    Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):332-340. PubMed ID: 35466712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.
    Wang Q; Xiang B; Chen S; Ji Y
    Australas J Dermatol; 2019 Aug; 60(3):181-185. PubMed ID: 30515761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Atenolol for Infantile Hemangioma: Case Series of 46 Infants.
    Calderón-Castrat X; Velásquez F; Castro R; Ballona R
    Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):59-62. PubMed ID: 31759456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.
    Ji Y; Chen S; Wang Q; Xiang B; Xu Z; Zhong L; Yang K; Lu G; Qiu L
    Sci Rep; 2018 Mar; 8(1):4264. PubMed ID: 29523832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term neurocognitive functioning of children treated with propranolol or atenolol for infantile hemangioma.
    Hermans MM; Rietman AB; Schappin R; de Laat PCJ; Mendels EJ; Breur JMPJ; Langeveld HR; de Wildt SN; Breugem CC; de Graaf M; Raphael MF; Pasmans SGMA
    Eur J Pediatr; 2023 Feb; 182(2):757-767. PubMed ID: 36478294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of infantile hemangiomas treated with atenolol.
    Ballona R; Zevallos J; Núñez J
    Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial.
    Bauman NM; McCarter RJ; Guzzetta PC; Shin JJ; Oh AK; Preciado DA; He J; Greene EA; Puttgen KB
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):323-30. PubMed ID: 24526257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.
    de Graaf M; Raphael MF; Breugem CC; Knol MJ; Bruijnzeel-Koomen CA; Kon M; Breur JM; Pasmans SG
    J Plast Reconstr Aesthet Surg; 2013 Dec; 66(12):1732-40. PubMed ID: 24011909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined low-dose oral propranolol and oral prednisolone as first-line treatment in periocular infantile hemangiomas.
    Koay AC; Choo MM; Nathan AM; Omar A; Lim CT
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):309-11. PubMed ID: 21542771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol Therapy for Problematic Infantile Hemangioma.
    Ng M; Knuth C; Weisbrod C; Murthy A
    Ann Plast Surg; 2016 Mar; 76(3):306-10. PubMed ID: 26010350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of oral propranolol in infantile hemangioma.
    Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
    N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
    Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
    Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.